Liposome purchase completed by Elan

Elan Corporation has completed its previously announced acquisition of The Liposome Company, following approval by the shareholders of Liposome last Friday, the company said at the weekend. The deal is a strategic step for Elan into the oncology market and will see Liposome operate as a separate business unit within Elan.